![Jürgen Feuerstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jürgen Feuerstein
Vorstandsvorsitzender bei be imaging GmbH
Profil
Jürgen Feuerstein is currently the Co-Managing Director at be imaging GmbH.
Previously, he served as a Member-Supervisory Board at SANOCHEMIA Pharmazeutika GmbH from 2019 to 2020.
Aktive Positionen von Jürgen Feuerstein
Unternehmen | Position | Beginn |
---|---|---|
be imaging GmbH
![]() be imaging GmbH Medical DistributorsDistribution Services Part of Bender Gruppe, be imaging GmbH is a German company that wholesales pharmaceutical products. The company is based in Baden-Baden, Germany. The company was founded in 2004 by Veronika Eckhardt. Veronika Eckhardt has been the CEO since 2004. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jürgen Feuerstein
Unternehmen | Position | Ende |
---|---|---|
SANOCHEMIA PHARMAZEUTIKA AG | Direktor/Vorstandsmitglied | 01.08.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
be imaging GmbH
![]() be imaging GmbH Medical DistributorsDistribution Services Part of Bender Gruppe, be imaging GmbH is a German company that wholesales pharmaceutical products. The company is based in Baden-Baden, Germany. The company was founded in 2004 by Veronika Eckhardt. Veronika Eckhardt has been the CEO since 2004. | Distribution Services |
SANOCHEMIA Pharmazeutika GmbH
![]() SANOCHEMIA Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria. | Health Technology |